190 related articles for article (PubMed ID: 18433909)
1. Discovery of synergistic permeation enhancers for oral drug delivery.
Whitehead K; Karr N; Mitragotri S
J Control Release; 2008 Jun; 128(2):128-33. PubMed ID: 18433909
[TBL] [Abstract][Full Text] [Related]
2. Modulation of ganciclovir intestinal absorption in presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
J Pharm Sci; 2007 Oct; 96(10):2710-22. PubMed ID: 17680662
[TBL] [Abstract][Full Text] [Related]
3. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
4. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
5. Development of a Non-Aqueous Dispersion to Improve Intestinal Epithelial Flux of Poorly Permeable Macromolecules.
Maher S; Medani M; Carballeira NN; Winter DC; Baird AW; Brayden DJ
AAPS J; 2017 Jan; 19(1):244-253. PubMed ID: 27739012
[TBL] [Abstract][Full Text] [Related]
6. Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.
Perera G; Barthelmes J; Vetter A; Krieg C; Uhlschmied C; Bonn GK; Bernkop-Schnürch A
Drug Deliv; 2011 Aug; 18(6):415-23. PubMed ID: 21554106
[TBL] [Abstract][Full Text] [Related]
7. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
Fein KC; Gleeson JP; Newby AN; Whitehead KA
Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers.
Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065
[TBL] [Abstract][Full Text] [Related]
9. Safe and effective permeation enhancers for oral drug delivery.
Whitehead K; Karr N; Mitragotri S
Pharm Res; 2008 Aug; 25(8):1782-8. PubMed ID: 18058001
[TBL] [Abstract][Full Text] [Related]
10. The pH of Piperazine Derivative Solutions Predicts Their Utility as Transepithelial Permeation Enhancers.
Lamson NG; Cusimano G; Suri K; Zhang A; Whitehead KA
Mol Pharm; 2016 Feb; 13(2):578-85. PubMed ID: 26730955
[TBL] [Abstract][Full Text] [Related]
11. In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
Shah P; Jogani V; Mishra P; Mishra AK; Bagchi T; Misra A
Drug Dev Ind Pharm; 2008 Mar; 34(3):279-88. PubMed ID: 18363143
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules.
Parmentier J; Hartmann FJ; Fricker G
Eur J Pharm Biopharm; 2010 Nov; 76(3):394-403. PubMed ID: 20849953
[TBL] [Abstract][Full Text] [Related]
13. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
14. Combining Chemical Permeation Enhancers for Synergistic Effects.
du Toit T; Malan MM; Lemmer HJ; Gouws C; Aucamp ME; Breytenbach WJ; Hamman JH
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):575-86. PubMed ID: 25939330
[TBL] [Abstract][Full Text] [Related]
15. Efficacious intestinal permeation enhancement induced by the sodium salt of 10-undecylenic acid, a medium chain fatty acid derivative.
Brayden DJ; Walsh E
AAPS J; 2014 Sep; 16(5):1064-76. PubMed ID: 24961919
[TBL] [Abstract][Full Text] [Related]
16. In silico modelling of permeation enhancement potency in Caco-2 monolayers based on molecular descriptors and random forest.
Welling SH; Clemmensen LK; Buckley ST; Hovgaard L; Brockhoff PB; Refsgaard HH
Eur J Pharm Biopharm; 2015 Aug; 94():152-9. PubMed ID: 26004819
[TBL] [Abstract][Full Text] [Related]
17. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
18. Monoketocholate can decrease transcellular permeation of methotrexate across Caco-2 cell monolayers and reduce its intestinal absorption in rat.
Chen G; Fawcett JP; Mikov M; Tucker IG
J Pharm Pharmacol; 2009 Jul; 61(7):953-9. PubMed ID: 19589239
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of intestinal absorption of poorly absorbed hydrophilic compounds by simultaneous use of mucolytic agent and non-ionic surfactant.
Takatsuka S; Kitazawa T; Morita T; Horikiri Y; Yoshino H
Eur J Pharm Biopharm; 2006 Jan; 62(1):52-8. PubMed ID: 16289777
[TBL] [Abstract][Full Text] [Related]
20. Transepithelial electrical resistance is not a reliable measurement of the Caco-2 monolayer integrity in Transwell.
Mukherjee T; Squillantea E; Gillespieb M; Shao J
Drug Deliv; 2004; 11(1):11-8. PubMed ID: 15168786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]